Strategies to reduce the burden of venous thromboembolism.

F. Piovella,M. Barone
Haematologica
Abstract:Venous thromboembolism (VTE) is a serious and potentially fatal illness. It affects not only hospitalized patients and those undergoing major surgery, but also patients not admitted to hospital and otherwise healthy ambulatory individuals.1-4 VTE produces few specific symptoms and its diagnosis remains a challenge;5 the first clinical presentation may be fatal pulmonary embolism (PE). Furthermore, undetected deep-vein thrombosis (DVT) may lead to long-term morbidity from postthrombotic syndrome, and places patients at risk of recurrent DVT.6 Deep-vein thrombosis and PE are viewed in the medical literature as different clinical manifestations of the same disease – VTE. In this review we discuss methods for diagnosing VTE, and outline current recommendations for prophylaxis and treatment. However, current management of patients with VTE is suboptimal since, despite the existence of a wide range of therapies for the prevention or treatment of this disease, a significant proportion of patients still suffer thrombotic complications. This may be due to underutilization of prophylaxis in patients at risk and the generally silent nature of the disease, but also to inadequate antithrombotic therapies. There is a need for new anticoagulant agents with better efficacy and safety profiles to reduce the morbidity and mortality associated with this common yet preventable disease.
What problem does this paper attempt to address?